Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Successful use of the dilated right spermatic cord vein for renal transplantation in a patient with congenital hypoplasia of the inferior vena cava.
Guo FF, Shao ZQ, Li HL, Wang GJ, Zhu WB.
Transplant Proc. 2011 Dec;43(10):4002-4.
Related citations
Does ultrasonic energy for surgical dissection reduce the incidence of renal transplant lymphocele?
Nelson EW, Gross ME, Mone MC, Hansen HJ, Sheng X, Cannon KM, Alder S.
Transplant Proc. 2011 Dec;43(10):3755-9.
Routine short-term ureteral stent in living donor renal transplantation: introduction of a simple stent removal technique without using anesthesia and cystoscope.
Dong J, Lu J, Zu Q, Yang S, Sun S, Cai W, Zhang L, Zhang X.
Transplant Proc. 2011 Dec;43(10):3747-50.
Patterns of IgG subclass deposits in membranous glomerulonephritis in renal allografts.
Kearney N, Podolak J, Matsumura L, Houghton D, Troxell M.
Transplant Proc. 2011 Dec;43(10):3743-6.
Urinary metabolomics in monitoring acute tubular injury of renal allografts: a preliminary report.
Wang J, Zhou Y, Xu M, Rong R, Guo Y, Zhu T.
Transplant Proc. 2011 Dec;43(10):3738-42.
The seroprevalence of Helicobacter pylori infection in renal transplant recipients.
Khameneh ZR, Sepehrvand N, Hatami S, Afshari AT.
Transplant Proc. 2011 Dec;43(10):3720-2.
Opportunistic posttransplantation virus infections in renal transplant recipients.
Hu JH, Zhao H, Huang YP, Zhang X, Gao HN, Yang MF, Fan J, Ma WH.
Transplant Proc. 2011 Dec;43(10):3715-9.
Efficacy and safety of changing from cyclosporine C0 to C2 monitoring in stable recipients following renal transplantation: a prospective cohort study.
Zhang Y, Zhang XD, Wang Y.
Transplant Proc. 2011 Dec;43(10):3697-701.
Lymphocyte ATP immune cell function assay in pediatric renal transplants: is it useful?
Vyas S, Roberti I.
Transplant Proc. 2011 Dec;43(10):3675-8.
Better actual 10-year renal transplant outcomes of 80% reduced cyclosporine exposure with sirolimus base therapy compared with full cyclosporine exposure without or with concomittant sirolimus treatment.
Pliszczynski J, Kahan BD.
Transplant Proc. 2011 Dec;43(10):3657-68.
Public opinion on renal transplantation in Brunei Darussalam.
Teo TT, Hossain MM, Zinna S, Liew YP, Tan J.
Transplant Proc. 2011 Dec;43(10):3599-603.
Oxidative stress and renal interstitial fibrosis in patients after renal transplantation: current state of knowledge.
Kędzierska K, Domański M, Sporniak-Tutak K, Dołęgowska B, Ciechanowski K.
Transplant Proc. 2011 Dec;43(10):3577-83. Review.
Long-term evolution of the mineral metabolism after renal transplantation: a prospective, single-center cohort study.
Van de Cauter J, Sennesael J, Haentjens P.
Transplant Proc. 2011 Nov;43(9):3470-5.
The first two cadaveric renal transplantations in Blida, Algeria.
Si-ahmed EM; Blida Transplantation Team.
Transplant Proc. 2011 Nov;43(9):3431-2.
Cost-effectiveness analysis of the early conversion of tacrolimus to mammalian target of rapamycin inhibitors in patients with renal transplantation.
Gamboa O, Montero C, Mesa L, Benavides C, Reino A, Torres RE, Castillo JS.
Transplant Proc. 2011 Nov;43(9):3367-76.
Barriers and strategies for taking medicines in adult patients with renal transplantation.
Cedillo-Galindo H, Gracida C.
Transplant Proc. 2011 Nov;43(9):3364-6.
Clinical description and evolution of renal transplant pediatric patients treated with alemtuzumab.
Velez C, Zuluaga G, Ocampo C, Aristizabal A, Serna LM, Serrano Gayubo AK, Florez JA, Zuleta JJ, Vanegas Ruiz JJ.
Transplant Proc. 2011 Nov;43(9):3350-4.
Growth, chronic kidney disease and pediatric kidney transplantation: is it useful to use recombinant growth hormone in Colombian children with renal transplant?
Castañeda DA, López LF, Ovalle DF, Buitrago J, Rodríguez D, Lozano E.
Transplant Proc. 2011 Nov;43(9):3344-9.
Utilization of advanced-age donors in renal transplantation.
Olaverri JG, Mora Christian J, Elorrieta P, Esnaola K, Rodríguez P, Marrón I, Uriarte I, Landa MJ, Zarraga S, Gainza FJ, Aranzabal J, Zabala JA, Pertusa C.
Transplant Proc. 2011 Nov;43(9):3340-3.
De novo use of everolimus with elimination or minimization of cyclosporine in renal transplant recipients.
Novoa PA, Grinyó JM, Ramos FJ, Errasti P, Franco A, Aldana G, Pefaur J, Marti-Cuadros AM, Otero AB, Saval N, Oppenheimer F.
Transplant Proc. 2011 Nov;43(9):3331-9.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on